However, few studies have analyzed the effects of chronic donepezil treatment on the cognitive functions of intact S3I-201 supplier animals.
Objectives The cognitive functions of healthy young rats treated chronically with the acetylcholinesterase inhibitor donepezil were evaluated using a wide behavioral test battery.
Results Chronic treatment with donepezil ameliorated memory functions and explorative strategies,
speeded up the acquisition of localizing knowledge, augmented responsiveness to the context, and reduced anxiety levels. However, it did not affect spatial span, modify motivational levels, or influence associative learning.
Conclusions The present findings show the specific profile of donepezil action on cognitive functions in the presence of unaltered cholinergic neurotransmission systems.”
“Germinal centres are receiving renewed attention following recent intravital multi-photon imaging studies. These data have shed new light on longstanding questions about the spatial organisation of germinal centres, B-cell migration, selection and differentiation. Mathematical models have proven invaluable in the analysis of intravital motility
data, and have predicted novel B-cell selection mechanisms that are now supported by experimental SCH772984 mw findings. We argue that mathematical modelling adds a different vantage point to experimental data and provides a quantitative and systematic analysis of hypotheses and theories in immunology. Furthermore, the well-characterised nature of the germinal centre provides an excellent proving ground for mathematical
modelling.”
“Overexpression of neuronal adaptor protein X11 beta has been shown to next decrease the production of amyloid-beta, a toxic peptide deposited in Alzheimer’s disease brains. Therefore, manipulation of the X11 beta level may represent a potential therapeutic strategy for Alzheimer’s disease. As X11 beta expression can be regulated at the transcription level, we determined the genomic organization and the promoter of the human X11 beta gene, amyloid beta A4 precursor protein-binding family A member 2 (APBA2). By RNA ligase-mediated rapid amplification of cDNA ends, a single APBA2 transcription start site and the complete sequence of exon 1 were identified. The APBA2 promoter was located upstream of exon 1 and was more active in neurons. The core promoter contains several CpG dinucleotides, and was strongly suppressed by DNA methylation. In addition, mutagenesis analysis revealed a putative Pax5-binding site within the promoter. Together, APBA2 contains a potent neuronal promoter whose activity may be regulated by DNA methylation and Pax5. NeuroReport 23: 146-151 (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.”
“Rationale More data are needed to guide “”next step”" strategies for patients with generalized anxiety disorder (GAD) remaining symptomatic despite initial pharmacotherapy.